Viking Global Investors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,569,545
| Closed | -$58.5M | – | 93 |
|
|
2023
Q1 | $58.5M | Sell |
1,569,545
-451,865
| -22% | -$16.8M | 0.27% | 60 |
|
|
2022
Q4 | $70.5M | Buy |
2,021,410
+132,343
| +7% | +$4.62M | 0.35% | 56 |
|
|
2022
Q3 | $106M | Sell |
1,889,067
-339,316
| -15% | -$19M | 0.49% | 53 |
|
|
2022
Q2 | $115M | Sell |
2,228,383
-240,377
| -10% | -$12.4M | 0.53% | 50 |
|
|
2022
Q1 | $179M | Buy |
2,468,760
+889,224
| +56% | +$64.6M | 0.73% | 38 |
|
|
2021
Q4 | $187M | Buy |
1,579,536
+300,005
| +23% | +$35.5M | 0.54% | 52 |
|
|
2021
Q3 | $172M | Buy |
1,279,531
+304,439
| +31% | +$40.8M | 0.47% | 60 |
|
|
2021
Q2 | $158M | Buy |
+975,092
| New | +$158M | 0.48% | 49 |
|